John Tallarico Ph.D., Novartis
John Tallarico leads Discovery Sciences at Novartis, a global team driving innovation at the frontiers of chemistry, biology, and data science. In this role, John’s mission is focused on the early stages of therapeutic discovery, including target identification, target validation, and moving early discoveries into the drug discovery pipeline. John has helped shape Novartis’s approaches to emerging therapeutic modalities to invent new medicines across all Novartis therapeutic areas. A former academic and biotech founder, he brings a deep scientific perspective to strategic collaborations that bridge science and business.
